Notícias GlycoMimetics Inc - GLYC | Ações NASDAQ | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

As Melhores Corretoras Online

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
GlycoMimetics Inc (GLYC)
GlycoMimetics Inc (GLYC) Notícias

GlycoMimetics Inc (GLYC)

0,242

0,0255

(11,78%)

Fechado 25 Dezembro 6:00PM

Atrasado por 15 minutos

0,2382

-0,0038

(-1,57%)

Após o horário de negociação: 6:56PM

Atrasado por 15 minutos

Ferramentas de nível profissional para investidores individuais.

Form 8-K - Current report

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

GlycoMimetics Announces Strategic Review and Corporate Restructuring Plan

Form 8-K - Current report

Form 8-K - Current report

GlycoMimetics Announces Comprehensive Results from Pivotal Phase 3 Study of Uproleselan in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)

GlycoMimetics to Host Key Opinion Leader Event to Review Comprehensive Results from Pivotal Phase 3 Study of Uproleselan in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) on June 4, 2024

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

GlycoMimetics Announces Results of Pivotal Phase 3 Study of Uproleselan in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)

GlycoMimetics to Report First Quarter 2024 Financial Results on May 9, 2024

GlycoMimetics Reports Highlights and Financial Results for Fourth Quarter and Full Year 2023

GlycoMimetics to Report Fourth Quarter and 2023 Full Year Financial Results on March 27, 2024

Form 8-K - Current report

GlycoMimetics to Participate in Upcoming Cowen 44th Annual Health Care Conference

1
2
Próxima

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições